Clinical practice guideline on diagnosis and treatment of hyponatraemia.
By G. Spasovski, R. Vanholder, B. Allolio, Djillali Annane, S. Ball, D. Bichet, G. Decaux, W. Fenske, E. Hoorn, C. Ichai and 7 more. European Journal of Endocrinology, 2014
656 citations recorded by the source corpus.
Subfields: Molecular Biology, Physiology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/738a17a2871250fc6af2ab0086338fa310f7eb16
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- P. Angeli
- S. Biggins
- M. Bernardi
- P. Ginés
- Paulo Angeli
- C. Villanueva
- G. Garcia‐Tsao
- C. Francoz
Citations in the corpus
- Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases (2021, background): “Treatment of hypervolemic hyponatremia includes fluid restriction, reduction or discontinuation of diuretics and laxatives, administration of hyperoncotic albumin, and/or vasopressin receptor antagonists (“vaptans”) (116-122).”
- EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. (2018, background): “In practice, after an initial rapid correction aimed at attenuating clinical symptoms (5 mmol/L in the first hour), serum sodium concentration should not increase more than 8 mmol/L per day [143].”